RecruitingNot applicableNCT07408479

Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mondelēz International, Inc.
Principal Investigator
Anne-Laure Castell, MD
Centre de Recherche en Nutrition Humaine Rhône-Alpes
Intervention
Balanced diet high in Slowly Digestible Starch and Resistant Starch(other)
Enrollment
40 target
Eligibility
18-75 years · All sexes
Timeline
2025 – 2028

Study locations (1)

Collaborators

Centre de Recherche en Nutrition Humaine Rhone-Alpe · Unite MetaGenoPolis INRAE

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07408479 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome →

← Back to all trials